Comparison of a Multiplexed Fluorescent Covalent Microsphere Immunoassay and an Enzyme-Linked Immunosorbent Assay for Measurement of Human Immunoglobulin G Antibodies to Anthrax Toxins

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 1, 2004, Pages 50-55

  Biagini, Raymond E ^a   Sammons, Deborah L ^a   Smith, Jerome P ^a   MacKenzie, Barbara A ^a   Striley, Cynthia A F ^a   Semenova, Vera ^b   Steward Clark, Evelen ^b   Stamey, Karen ^b   Freeman, Alison E ^b   Quinn, Conrad P ^b   Snawder, John E ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; BACILLUS ANTHRACIS PROTECTIVE ANTIGEN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; LETHAL FACTOR ANTIBODY; MICROSPHERE; PROTECTIVE ANTIGEN ANTIBODY; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBODY TITER; ARTICLE; BACILLUS ANTHRACIS; BIOTECHNOLOGY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE COVALENT MICROBEAD IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; LETHAL GENE; LUMINEX XMAP TECHNOLOGY; MINIMUM DETECTABLE CONCENTRATION; MULTIPLEXED FLUORESCENT COVALENT MICROSPHERE IMMUNOASSAY; PRIORITY JOURNAL;

ADULT; ANTHRAX; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUOROIMMUNOASSAY; HUMANS; IMMUNOGLOBULIN G; MICROSPHERES;

EID: 9144230037     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.1.50-55.2004     Document Type: Article

References (19)

1. Bardsley, W. G., and P. B. McGinlay. 1987. The use of non-linear regression analysis and the F test for model discrimination with dose-response curves and ligand binding data. J. Theor. Biol. 126:183-201.
2. Biagini, R. E., D. M. Murphy, D. L. Sammons, J. P. Smith, C. A. Striley, and B. A. MacKenzie. 2002. Development of multiplexed fluorescence microbead covalent assays (FMCAs) for pesticide biomonitoring. Bull. Environ. Contam. Toxicol. 68:470-477.
3. Biagini, R. E., S. A. Schlottmann, D. L. Sammons, J. P. Smith, J. C. Snawder, C. A. Striley, B. A. MacKenzie, and D. N. Weissman. 2003. Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides. Clin. Diagn. Lab. Immunol. 10:744-750.
4. De Jager, W., H. Te Velthuis, B. J. Prakken, W. Kuis, and G. T. Rijkers. 2003. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10:133-139.
5. Hornung, R., and L. Reed. 1990. Estimate of average concentration in the presence of non-detectable values. Appl. Occup. Environ. Hyg. 5:46-51.
6. Iacono-Connors, L. C., J. Novak, C. Rossi, J. Mangiafico, and T. Ksiazek. 1994. Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies. Clin. Diagn. Lab. Immunol. 1:78-82.
7. Jacobson, R. H. 1998. Validation of scrological assays for diagnosis of infectious diseases. Rev. Sci. Tech. 17:469-526.
8. Johnson-Winegar, A. 1984. Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies. J. Clin. Microbiol. 20:357-361.
9. Leppla, S. 1991. Purification and characterization of adenyl cyclase from Bacillus anthracis. Methods Enzymol. 195:153-168.
10. Nix, B., and D. Wild. 2001. Calibration curve-fitting, p. 198-210. hi D. Wild (ed.), The immunoassay handbook. Nature Publishing Group, New York, N.Y.
11. O'Connell, M., B. Belanger, and P. Haaland. 1993. Calibration and assay development using the four-parameter logistic model. Chemometrics Intell. Lab. Systems 20:97-114.
12. Park, S., and S. Leppla. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expression Purif. 18:293-302.
13. Pickering, J. W., T. B. Martins, R. W. Greer, M. C. Schroder, M. E. Astill, C. M. Litwin, S. W. Hildreth, and H. R. Hill. 2002. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am. J. Clin. Pathol. 117:589-596.
14. Plikaytis, B. D., S. H. Turner, L. L. Gheesling, and G. M. Carlone. 1991. Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29:1439-1446.
15. Quinn, C. P., V. A. Semenova, C. M. Elie, S. Romero-Steiner, C. Greene, H. Li, K. Stamey, E. Steward-Clark, D. S. Schmidt, E. Mothershed, J. Pruckler, S. Schwartz, R. F. Benson, L. O. Helsel, P. F. Holder, S. E. Johnson, M. Kellum, T. Messmer, W. L. Thacker, L. Besser, B. D. Plikaytis, T. H. Taylor, Jr., A. E. Freeman, K. J. Wallace, P. Dull, J. Sejvar, E. Bruce, R. Moreno, A. Schuchat, J. R. Lingappa, S. K. Martin, J. Walls, M. Bronsdon, G. M. Carlone, M. Bajani-Ari, D. A. Ashford, D. S. Stephens, and B. A. Perkins. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis. 8:1103-1110.
16. Sirisanthana, T., K. E. Nelson, J. W. Ezzell, and T. G. Abshire. 1988. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand. Am. J. Trop. Med. Hyg. 39:575-581.
17. Turnbull, P. C., S. H. Leppla, M. G. Broster, C. P. Quinn, and J. Melling. 1988. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol. Immunol. 177:293-303.
18. Vignali, D. A. 2000. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 243:243-255.
19. Wasserman, G. M., J. D. Grabenstein, P. R. Pittman, M. V. Rubertone, P. P. Gibbs, L. Z. Wang, and L. G. Golder. 2003. Analysis of adverse events after anthrax immunization in US Army medical personnel. J. Occup. Environ. Med. 45:222-233.